Difference between revisions of "Part:BBa K5237024"

 
(3 intermediate revisions by 2 users not shown)
Line 3: Line 3:
 
<html>
 
<html>
 
<style>
 
<style>
  p {
+
    p {
    text-align: justify;
+
        text-align: justify;
    margin-right: 25px;
+
        margin-right: 25px;
    font-style: normal;
+
        font-style: normal;
  }
+
    }
  
  section {
+
    section {
    margin-left: 25px;
+
        margin-left: 25px;
    margin-right: 25px;
+
        margin-right: 25px;
    margin-top: 25px;
+
        margin-top: 25px;
  }
+
    }
  
  .thumb {
+
    .thumb {
    width: 100%;
+
        width: 100%;
  }
+
    }
  
  table,
+
    table,
  th,
+
    th,
  td {
+
    td {
    border: 0.5px solid black;
+
        border: 0.5px solid black;
    border-collapse: collapse;
+
        border-collapse: collapse;
    padding: 5px;
+
        padding: 5px;
  }
+
    }
  
  .thumbcaption {
+
    .thumbcaption {
    text-align: justify !important;
+
        text-align: justify !important;
  }
+
    }
  
  
  a[href ^="https://"],
+
    a[href ^="https://"],
  .link-https {
+
    .link-https {
    background: none !important;
+
        background: none !important;
    padding-right: 0px !important;
+
        padding-right: 0px !important;
  }
+
    }
 
</style>
 
</style>
  
 
<body>
 
<body>
  <!-- Part summary -->
+
    <!-- Part summary -->
  <section id="1">
+
    <section>
    <h1>TRE-minimal promoter- firefly luciferase</h1>
+
        <h1>TRE-minimal Promoter - Firefly Luciferase</h1>
    <p>
+
        <p>
      This part contains the tetO binding site (BBa_K5237019) , a minimal promoter and a firefly luciferase gene. With a
+
            This part contains the tetO binding site (BBa_K5237019), a minimal promoter and a firefly luciferase gene.
      VP64 coming in close proximity to the minimal promoter transcription factors are recruited, initiating expression
+
            With a
      of firefly luciferase. The described mechanism is utilized in our enhancer hijacking assay for prove of Cas
+
            VP64 coming in close proximity to the minimal promoter transcription factors are recruited, initiating
      stapling.
+
            expression
 +
            of firefly luciferase. The described mechanism is utilized in our enhancer hijacking assay for prove of Cas
 +
            stapling.
  
    </p>
+
        </p>
    <p>&nbsp;</p>
+
        <p> </p>
  </section>
+
    </section>
  <div id="toc" class="toc">
+
    <div class="toc" id="toc">
    <div id="toctitle">
+
        <div id="toctitle">
      <h1>Contents</h1>
+
            <h1>Contents</h1>
 +
        </div>
 +
        <ul>
 +
            <li class="toclevel-1 tocsection-1"><a href="#1"><span class="tocnumber">1</span> <span
 +
                        class="toctext">Sequence
 +
                        Overview</span></a>
 +
            </li>
 +
            <li class="toclevel-1 tocsection-2"><a href="#2"><span class="tocnumber">2</span> <span
 +
                        class="toctext">Usage and
 +
                        Biology</span></a>
 +
            </li>
 +
            <li class="toclevel-1 tocsetction-3"><a href="#3"><span class="tocnumber">3</span> <span
 +
                        class="toctext">Assembly
 +
                        and Part eEvolution</span></a>
 +
            </li>
 +
            <li class="toclevel-1 tocsection-5"><a href="#4"><span class="tocnumber">4</span> <span
 +
                        class="toctext">Results</span></a>
 +
            </li>
 +
            <li class="toclevel-1 tocsection-8"><a href="#5"><span class="tocnumber">5</span> <span
 +
                        class="toctext"><i>In Silico</i> Characterization using DaVinci</span></a>
 +
                <ul>
 +
                    <li class="toclevel-2 tocsection-9"><a href="#5.1"><span class="tocnumber">5.1</span> <span
 +
                                class="toctext">Enhancer Hijacking is Successfully Studied <I>In silico</i></span></a>
 +
                    </li>
 +
                    <li class="toclevel-2 tocsection-10"><a href="#5.2"><span class="tocnumber">5.2</span> <span
 +
                                class="toctext">Cas Staple Forces Do Not Distrub DNA Strand Integrity</span></a></li>
 +
                    <li class="toclevel-2 tocsection-11"><a href="#5.3"><span class="tocnumber">5.3</span> <span
 +
                                class="toctext">DaVinci Helps to Design Multi-Staple Arrangements</span></a></li>
 +
                </ul>
 +
            </li>
 +
            <li class="toclevel-1 tocsection-8"><a href="#6"><span class="tocnumber">6</span> <span
 +
                        class="toctext">References</span></a>
 +
            </li>
 +
        </ul>
 
     </div>
 
     </div>
     <ul>
+
     <section>
      <li class="toclevel-1 tocsection-1"><a href="#1"><span class="tocnumber">1</span> <span class="toctext">Sequence
+
        <p><br /><br /></p>
            overview</span></a>
+
        <font size="5"><b>The PICasSO Toolbox </b> </font>
      </li>
+
        <div class="thumb" style="margin-top:10px;"></div>
      <li class="toclevel-1 tocsection-2"><a href="#2"><span class="tocnumber">2</span> <span class="toctext">Usage and
+
        <div class="thumbinner" style="width:550px"><img alt="" class="thumbimage"
            Biology</span></a>
+
                src="https://static.igem.wiki/teams/5237/wetlab-results/registry-part-collection-engineering-cycle-example-overview.svg"
      </li>
+
                style="width:99%;" />
      <li class="toclevel-1 tocsetction-3"><a href="#3"><span class="tocnumber">3</span> <span class="toctext">Assembly
+
            <div class="thumbcaption">
            and part evolution</span></a>
+
                <i><b>Figure 1: How our part collection can be used to engineer new staples</b></i>
      </li>
+
            </div>
      <li class="toclevel-1 tocsection-5"><a href="#4"><span class="tocnumber">4</span> <span
+
        </div>
            class="toctext">Results</span></a>
+
        <p>
      </li>
+
            <br />
      <li class="toclevel-1 tocsection-8"><a href="#5"><span class="tocnumber">5</span> <span
+
            While synthetic biology has in the past focused on engineering the genomic sequence of organisms, the <b>3D
            class="toctext">References</span></a>
+
                spatial organization</b> of DNA is well-known to be an important layer of information encoding in
      </li>
+
            particular in eukaryotes, playing a crucial role in
    </ul>
+
            gene regulation and hence
  </div>
+
            cell fate, disease development, evolution, and more. However, tools to precisely manipulate and control the
  <section>
+
            genomic spatial
    <p><br><br></p>
+
            architecture are limited, hampering the exploration of
    <font size="5"><b>The PICasSO Toolbox </b> </font>
+
            3D genome engineering in synthetic biology. We - the iGEM Team Heidelberg 2024 - have developed PICasSO, a
 
+
            <b>powerful
    <div class="thumb" style="margin-top:10px;"></div>
+
                molecular toolbox for rationally engineering genome 3D architectures</b> in living cells, based on
    <div class="thumbinner" style="width:550px"><img alt=""
+
            various DNA-binding proteins.
        src="https://static.igem.wiki/teams/5237/wetlab-results/registry-part-collection-engineering-cycle-example-overview.svg"
+
        </p>
        style="width:99%;" class="thumbimage">
+
        <p>
      <div class="thumbcaption">
+
            The <b>PICasSO</b> part collection offers a comprehensive, modular platform for precise manipulation and
        <i><b>Figure 1: How our part collection can be used to engineer new staples</b></i>
+
            <b>re-programming
      </div>
+
                of DNA-DNA interactions</b> using engineered "protein staples" in living cells. This enables
    </div>
+
            researchers to recreate naturally occurring alterations of 3D genomic
    </div>
+
            interactions, such as enhancer hijacking in cancer, or to design entirely new spatial architectures for
 
+
            artificial gene regulation and cell function control.
 
+
            Specifically, the fusion of two DNA binding proteins enables to artificially bring otherwise distant genomic
    <p>
+
            loci into
      <br>
+
            spatial proximity.
      Next to the well-studied linear DNA sequence, the 3D spatial organization of DNA plays a crucial role in gene
+
            To unlock the system's full potential, we introduce versatile <b>chimeric CRISPR/Cas complexes</b>,
      regulation,
+
            connected either at
      cell fate, disease development and more. However, the tools to precisely manipulate this genomic architecture
+
            the protein or - in the case of CRISPR/Cas-based DNA binding moieties - the guide RNA level. These complexes
      remain limited, rendering it challenging to explore the full potential of the
+
            are
      3D genome in synthetic biology. We - iGEM Team Heidelberg 2024 - have developed PICasSO, a powerful molecular
+
            referred to as protein- or Cas staples, respectively. Beyond its
      toolbox based on various DNA-binding proteins to address this issue.
+
            versatility with regard to the staple constructs themselves, PICasSO includes <b>robust assay</b> systems to
    </p>
+
            support the engineering, optimization, and
    <p>
+
            testing of new staples <i>in vitro</i> and <i>in vivo</i>. Notably, the PICasSO toolbox was developed in a
      The <b>PICasSO</b> part collection offers a comprehensive, modular platform for precise manipulation and
+
            design-build-test-learn <b>engineering cycle closely intertwining wet lab experiments and computational
      re-programming
+
                modeling</b> and iterated several times, yielding a collection of well-functioning and -characterized
      of DNA-DNA interactions using protein staples in living cells, enabling researchers to recreate natural 3D genomic
+
            parts.
      interactions, such as enhancer hijacking, or to design entirely new spatial architectures for gene regulation.
+
        </p>
      Beyond its versatility, PICasSO includes robust assay systems to support the engineering, optimization, and
+
        <p>At its heart, the PICasSO part collection consists of three categories. <br /><b>(i)</b> Our <b>DNA-binding
      testing of new staples, ensuring functionality <i>in vitro</i> and <i>in vivo</i>. We took special care to include
+
                proteins</b>
      parts crucial for testing every step of the cycle (design, build, test, learn) when engineering new parts.
+
            include our
    </p>
+
            finalized Cas staple experimentally validated using an artificial "enhancer hijacking" system as well as
 
+
            "half staples" that can be combined by scientists to compose entirely
    <p>At its heart, the PICasSO part collection consists of three categories. <br><b>(i)</b> Our <b>DNA-binding
+
            new Cas staples in the future. We also include our Simple staples comprised of particularly small, simple
        proteins</b>
+
            and robust DNA binding domains well-known to the synthetic biology community, which serve as controls for
      include our
+
            successful stapling
      finalized enhancer hijacking Cas staple as well as half staples that can be used by scientists to compose entirely
+
            and can be further engineered to create alternative, simpler, and more compact staples. <br />
      new Cas staples in the future. We also include our Simple staples that serve as controls for successful stapling
+
            <b>(ii)</b> As <b>functional elements</b>, we list additional parts that enhance and expand the
      and can be further engineered to create alternative, simpler and more compact staples. <br>
+
            functionality of our Cas and
      <b>(ii)</b> As <b>functional elements</b>, we list additional parts that enhance the functionality of our Cas and
+
            Basic staples. These
      Basic staples. These
+
            consist of staples dependent on
      consist of
+
            cleavable peptide linkers targeted by cancer-specific proteases or inteins that allow condition-specific,
      protease-cleavable peptide linkers and inteins that allow condition-specific, dynamic stapling <i>in vivo</i>.
+
            dynamic stapling <i>in vivo</i>.
      Besides staple functionality, we also include the parts to enable the efficient delivery of PICasSO's constructs
+
            We also include several engineered parts that enable the efficient delivery of PICasSO's constructs into
      with our
+
            target cells, including mammalian cells,
      interkingdom conjugation system. <br>
+
            with our new
      <b>(iii)</b> As the final category of our collection, we provide parts that support the use of our <b>custom
+
            interkingdom conjugation system. <br />
        readout
+
            <b>(iii)</b> As the final category of our collection, we provide parts that underlie our <b>custom
        systems</b>. These include components of our established FRET-based proximity assay system, enabling users to
+
                readout
      confirm
+
                systems</b>. These include components of our established FRET-based proximity assay system, enabling
      accurate stapling. Additionally, we offer a complementary, application-oriented testing system for functional
+
            users to
      readouts via a luciferase reporter, which allows for straightforward experimental simulation of enhancer hijacking
+
            confirm
      in mammalian cells.
+
            accurate stapling. Additionally, we offer a complementary, application-oriented testing system based on a
    </p>
+
            luciferase reporter, which allows for straightforward experimental assessment of functional enhancer
    <p>
+
            hijacking events
      The following table gives a comprehensive overview of all parts in our PICasSO toolbox. <mark
+
            in mammalian cells.
        style="background-color: #FFD700; color: black;">The highlighted parts showed
+
        </p>
        exceptional performance as described on our iGEM wiki and can serve as a reference.</mark> The other parts in
+
        <p>
      the
+
            The following table gives a comprehensive overview of all parts in our PICasSO toolbox. <mark
      collection are versatile building blocks designed to provide future iGEMers with the flexibility to engineer their
+
                style="background-color: #FFD700; color: black;">The highlighted parts showed
      own custom Cas staples, enabling further optimization and innovation.<br>
+
                exceptional performance as described on our iGEM wiki and can serve as a reference.</mark> The other
    </p>
+
            parts in
    <p>
+
            the
      <font size="4"><b>Our part collection includes:</b></font><br>
+
            collection are versatile building blocks designed to provide future iGEMers with the flexibility to engineer
    </p>
+
            their
 
+
            own custom Cas staples, enabling further optimization and innovation in the new field of 3D genome
    <table style="width: 90%; padding-right:10px;">
+
            engineering.<br />
      <td colspan="3" align="left"><b>DNA-binding proteins: </b>
+
        </p>
        The building blocks for engineering of custom staples for DNA-DNA interactions with a modular system ensuring
+
        <p>
        easy assembly.</td>
+
            <font size="4"><b>Our part collection includes:</b></font><br />
      <tbody>
+
        </p>
        <tr bgcolor="#FFD700">
+
        <table style="width: 90%; padding-right:10px;">
          <td><a href="https://parts.igem.org/Part:BBa_K5237000" target="_blank">BBa_K5237000</a></td>
+
            <td align="left" colspan="3"><b>DNA-Binding Proteins: </b>
          <td>fgRNA Entry vector MbCas12a-SpCas9</td>
+
                Modular building blocks for engineering of custom staples to mediate defined DNA-DNA interactions <i>in
          <td>Entryvector for simple fgRNA cloning via SapI</td>
+
                    vivo</i></td>
        </tr>
+
            <tbody>
        <tr bgcolor="#FFD700">
+
                <tr bgcolor="#FFD700">
          <td><a href="https://parts.igem.org/Part:BBa_K5237001" target="_blank">BBa_K5237001</a></td>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237000" target="_blank">BBa_K5237000</a></td>
          <td>Staple subunit: dMbCas12a-Nucleoplasmin NLS</td>
+
                    <td>Fusion Guide RNA Entry Vector MbCas12a-SpCas9</td>
          <td>Staple subunit that can be combined with sgRNA or fgRNA and dCas9 to form a functional staple</td>
+
                    <td>Entry vector for simple fgRNA cloning via SapI</td>
        </tr>
+
                </tr>
        <tr bgcolor="#FFD700">
+
                <tr bgcolor="#FFD700">
          <td><a href="https://parts.igem.org/Part:BBa_K5237002" target="_blank">BBa_K5237002</a></td>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237001" target="_blank">BBa_K5237001</a></td>
          <td>Staple subunit: SV40 NLS-dSpCas9-SV40 NLS</td>
+
                    <td>Staple Subunit: dMbCas12a-Nucleoplasmin NLS</td>
          <td>Staple subunit that can be combined witha sgRNA or fgRNA and dCas12avto form a functional staple
+
                    <td>Staple subunit that can be combined with crRNA or fgRNA and dSpCas9 to form a functional staple
          </td>
+
                    </td>
        </tr>
+
                </tr>
        <tr>
+
                <tr bgcolor="#FFD700">
          <td><a href="https://parts.igem.org/Part:BBa_K5237003" target="_blank">BBa_K5237003</a></td>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237002" target="_blank">BBa_K5237002</a></td>
          <td>Cas Staple: SV40 NLS-dMbCas12a-dSpCas9-Nucleoplasmin NLS</td>
+
                    <td>Staple Subunit: SV40 NLS-dSpCas9-SV40 NLS</td>
          <td>Functional Cas staple that can be combined with sgRNA or fgRNA to bring two DNA strands into close
+
                    <td>Staple subunit that can be combined with a sgRNA or fgRNA and dMbCas12a to form a functional
            proximity
+
                        staple
          </td>
+
                    </td>
        </tr>
+
                </tr>
        <tr>
+
                <tr>
          <td><a href="https://parts.igem.org/Part:BBa_K5237004" target="_blank">BBa_K5237004</a></td>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237003" target="_blank">BBa_K5237003</a></td>
          <td>Staple subunit: Oct1-DBD</td>
+
                    <td>Cas Staple: SV40 NLS-dMbCas12a-dSpCas9-Nucleoplasmin NLS</td>
          <td>Staple subunit that can be combined to form a functional staple, for example with TetR.<br>
+
                    <td>Functional Cas staple that can be combined with sgRNA and crRNA or fgRNA to bring two DNA
            Can also be combined with a fluorescent protein as part of the FRET proximity assay</td>
+
                        strands into
        </tr>
+
                        close
        <tr>
+
                        proximity
          <td><a href="https://parts.igem.org/Part:BBa_K5237005" target="_blank">BBa_K5237005</a></td>
+
                    </td>
          <td>Staple subunit: TetR</td>
+
                </tr>
          <td>Staple subunit that can be combined to form a functional staple, for example with Oct1.<br>
+
                <tr>
            Can also be combined with a fluorescent protein as part of the FRET proximity assay</td>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237004" target="_blank">BBa_K5237004</a></td>
        </tr>
+
                    <td>Staple Subunit: Oct1-DBD</td>
        <tr>
+
                    <td>Staple subunit that can be combined to form a functional staple, for example with TetR.<br />
          <td><a href="https://parts.igem.org/Part:BBa_K5237006" target="_blank">BBa_K5237006</a></td>
+
                        Can also be combined with a fluorescent protein as part of the FRET proximity assay</td>
          <td>Simple staple: TetR-Oct1</td>
+
                </tr>
          <td>Functional staple that can be used to bring two DNA strands in close proximity</td>
+
                <tr>
        </tr>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237005" target="_blank">BBa_K5237005</a></td>
        <tr>
+
                    <td>Staple Subunit: TetR</td>
          <td><a href="https://parts.igem.org/Part:BBa_K5237007" target="_blank">BBa_K5237007</a></td>
+
                    <td>Staple subunit that can be combined to form a functional staple, for example with Oct1.<br />
          <td>Staple subunit: GCN4</td>
+
                        Can also be combined with a fluorescent protein as part of the FRET proximity assay</td>
          <td>Staple subunit that can be combined to form a functional staple, for example with rGCN4</td>
+
                </tr>
        </tr>
+
                <tr>
        <tr>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237006" target="_blank">BBa_K5237006</a></td>
          <td><a href="https://parts.igem.org/Part:BBa_K5237008" target="_blank">BBa_K5237008</a></td>
+
                    <td>Simple Staple: TetR-Oct1</td>
          <td>Staple subunit: rGCN4</td>
+
                    <td>Functional staple that can be used to bring two DNA strands in close proximity</td>
          <td>Staple subunit that can be combined to form a functional staple, for example with rGCN4</td>
+
                </tr>
        </tr>
+
                <tr>
        <tr>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237007" target="_blank">BBa_K5237007</a></td>
          <td><a href="https://parts.igem.org/Part:BBa_K5237009" target="_blank">BBa_K5237009</a></td>
+
                    <td>Staple Subunit: GCN4</td>
          <td>Mini staple: bGCN4</td>
+
                    <td>Staple subunit that can be combined to form a functional staple, for example with rGCN4</td>
          <td>
+
                </tr>
            Assembled staple with minimal size that can be further engineered</td>
+
                <tr>
        </tr>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237008" target="_blank">BBa_K5237008</a></td>
      </tbody>
+
                    <td>Staple Subunit: rGCN4</td>
      <td colspan="3" align="left"><b>Functional elements: </b>
+
                    <td>Staple subunit that can be combined to form a functional staple, for example with rGCN4</td>
        Protease-cleavable peptide linkers and inteins are used to control and modify staples for further optimization
+
                </tr>
        for custom applications</td>
+
                <tr>
      <tbody>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237009" target="_blank">BBa_K5237009</a></td>
        <tr bgcolor="#FFD700">
+
                    <td>Mini Staple: bGCN4</td>
          <td><a href="https://parts.igem.org/Part:BBa_K5237010" target="_blank">BBa_K5237010</a></td>
+
                    <td>
          <td>Cathepsin B-cleavable Linker: GFLG</td>
+
                        Assembled staple with minimal size that can be further engineered</td>
          <td>Cathepsin B-cleavable peptide linker that can be used to combine two staple subunits to make responsive
+
                </tr>
            staples</td>
+
            </tbody>
        </tr>
+
            <td align="left" colspan="3"><b>Functional Elements: </b>
        <tr>
+
                Protease-cleavable peptide linkers and inteins are used to control and modify staples for further
          <td><a href="https://parts.igem.org/Part:BBa_K5237011" target="_blank">BBa_K5237011</a></td>
+
                optimization
          <td>Cathepsin B Expression Cassette</td>
+
                for custom applications</td>
          <td>Expression Cassette for the overexpression of cathepsin B</td>
+
            <tbody>
        </tr>
+
                <tr bgcolor="#FFD700">
        <tr>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237010" target="_blank">BBa_K5237010</a></td>
          <td><a href="https://parts.igem.org/Part:BBa_K5237012" target="_blank">BBa_K5237012</a></td>
+
                    <td>Cathepsin B-cleavable Linker: GFLG</td>
          <td>Caged NpuN Intein</td>
+
                    <td>Cathepsin B-cleavable peptide linker that can be used to combine two staple subunits to make
          <td>A caged NpuN split intein fragment that undergoes protein <i>trans</i>-splicing after protease activation.
+
                        responsive
            Can be used to create functionalized staples
+
                        staples</td>
            units</td>
+
                </tr>
        </tr>
+
                <tr>
        <tr>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237011" target="_blank">BBa_K5237011</a></td>
          <td><a href="https://parts.igem.org/Part:BBa_K5237013" target="_blank">BBa_K5237013</a></td>
+
                    <td>Cathepsin B Expression Cassette</td>
          <td>Caged NpuC Intein</td>
+
                    <td>Expression cassette for the overexpression of cathepsin B</td>
          <td>A caged NpuC split intein fragment that undergoes protein <i>trans</i>-splicing after protease activation.
+
                </tr>
            Can be used to create functionalized staples
+
                <tr>
            units</td>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237012" target="_blank">BBa_K5237012</a></td>
        </tr>
+
                    <td>Caged NpuN Intein</td>
        <tr>
+
                    <td>A caged NpuN split intein fragment that undergoes protein <i>trans</i>-splicing after protease
          <td><a href="https://parts.igem.org/Part:BBa_K5237014" target="_blank">BBa_K5237014</a></td>
+
                        activation, which can be used to create functionalized staple
          <td>fgRNA processing casette</td>
+
                        subunits</td>
          <td>Processing casette to produce multiple fgRNAs from one transcript, that can be used for multiplexed 3D
+
                </tr>
            genome reprograming</td>
+
                <tr>
        </tr>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237013" target="_blank">BBa_K5237013</a></td>
        <tr>
+
                    <td>Caged NpuC Intein</td>
          <td><a href="https://parts.igem.org/Part:BBa_K5237015" target="_blank">BBa_K5237015</a></td>
+
                    <td>A caged NpuC split intein fragment that undergoes protein <i>trans</i>-splicing after protease
          <td>Intimin anti-EGFR Nanobody</td>
+
                        activation, which can be used to create functionalized staple
          <td>Interkindom conjugation between bacteria and mammalian cells, as alternative delivery tool for large
+
                        subunits</td>
            constructs</td>
+
                </tr>
        </tr>
+
                <tr>
        <tr>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237014" target="_blank">BBa_K5237014</a></td>
          <td><a href="https://parts.igem.org/Part:BBa_K4643003" target="_blank">BBa_K4643003</a></td>
+
                    <td>Fusion Guide RNA Processing Casette</td>
          <td>incP origin of transfer</td>
+
                    <td>Processing cassette to produce multiple fgRNAs from one transcript, that can be used for
          <td>Origin of transfer that can be cloned into the plasmid vector and used for conjugation as a means of
+
                        multiplexed 3D
            delivery</td>
+
                        genome reprogramming</td>
        </tr>
+
                </tr>
      </tbody>
+
                <tr>
      <td colspan="3" align="left"><b>Readout Systems: </b>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237015" target="_blank">BBa_K5237015</a></td>
        FRET and enhancer recruitment to measure proximity of stapled DNA in bacterial and mammalian living cells
+
                    <td>Intimin anti-EGFR Nanobody</td>
        enabling swift testing and easy development for new systems</td>
+
                    <td>Interkingdom conjugation between bacteria and mammalian cells, as an alternative delivery tool
      <tbody>
+
                        for
        <tr bgcolor="#FFD700">
+
                        large
          <td><a href="https://parts.igem.org/Part:BBa_K5237016" target="_blank">BBa_K5237016</a></td>
+
                        constructs</td>
          <td>FRET-Donor: mNeonGreen-Oct1</td>
+
                </tr>
          <td>FRET Donor-Fluorpohore fused to Oct1-DBD that binds to the Oct1 binding cassette. Can be used to visualize
+
                <tr>
            DNA-DNA
+
                    <td><a href="https://parts.igem.org/Part:BBa_K4643003" target="_blank">BBa_K4643003</a></td>
            proximity</td>
+
                    <td>IncP Origin of Transfer</td>
        </tr>
+
                    <td>Origin of transfer that can be cloned into the plasmid vector and used for conjugation as a
        <tr bgcolor="#FFD700">
+
                        means of
          <td><a href="https://parts.igem.org/Part:BBa_K5237017" target="_blank">BBa_K5237017</a></td>
+
                        delivery</td>
          <td>FRET-Acceptor: TetR-mScarlet-I</td>
+
                </tr>
          <td>Acceptor part for the FRET assay binding the TetR binding cassette. Can be used to visualize DNA-DNA
+
            </tbody>
            proximity</td>
+
            <td align="left" colspan="3"><b>Readout Systems: </b>
        </tr>
+
                FRET and enhancer recruitment readout systems to rapidly assess successful DNA stapling in bacterial and
        <tr>
+
                mammalian cells
          <td><a href="https://parts.igem.org/Part:BBa_K5237018" target="_blank">BBa_K5237018</a></td>
+
            </td>
          <td>Oct1 Binding Casette</td>
+
            <tbody>
          <td>DNA sequence containing 12 Oct1 binding motifs, compatible with various assays such as the FRET
+
                <tr bgcolor="#FFD700">
            proximity assay</td>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237016" target="_blank">BBa_K5237016</a></td>
        </tr>
+
                    <td>FRET-Donor: mNeonGreen-Oct1</td>
        <tr>
+
                    <td>FRET donor-fluorophore fused to Oct1-DBD that binds to the Oct1 binding cassette, which can be
          <td><a href="https://parts.igem.org/Part:BBa_K5237019" target="_blank">BBa_K5237019</a></td>
+
                        used to
          <td>TetR Binding Cassette</td>
+
                        visualize
          <td>DNA sequence containing 12 Oct1 binding motifs, can be used for different assays such as the FRET
+
                        DNA-DNA
            proximity assay</td>
+
                        proximity</td>
        </tr>
+
                </tr>
        <td><a href="https://parts.igem.org/Part:BBa_K5237020" target="_blank">BBa_K5237020</a></td>
+
                <tr bgcolor="#FFD700">
        <td>Cathepsin B-Cleavable Trans-Activator: NLS-Gal4-GFLG-VP64</td>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237017" target="_blank">BBa_K5237017</a></td>
        <td>Readout system that responds to protease activity. It was used to test cathepsin B-cleavable linker</td>
+
                    <td>FRET-Acceptor: TetR-mScarlet-I</td>
        </tr>
+
                    <td>Acceptor part for the FRET assay binding the TetR binding cassette, which can be used to
        <tr>
+
                        visualize
          <td><a href="https://parts.igem.org/Part:BBa_K5237021" target="_blank">BBa_K5237021</a></td>
+
                        DNA-DNA
          <td>NLS-Gal4-VP64</td>
+
                        proximity</td>
          <td>Trans-activating enhancer, that can be used to simulate enhancer hijacking</td>
+
                </tr>
        </tr>
+
                <tr>
        <td><a href="https://parts.igem.org/Part:BBa_K5237022" target="_blank">BBa_K5237022</a></td>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237018" target="_blank">BBa_K5237018</a></td>
        <td>mCherry Expression Cassette: UAS, minimal Promotor, mCherry</td>
+
                    <td>Oct1 Binding Casette</td>
        <td>Readout system for enhancer binding. It was used to test cathepsin B-cleavable linker</td>
+
                    <td>DNA sequence containing 12 Oct1 binding motifs, compatible with various assays such as the FRET
        </tr>
+
                        proximity assay</td>
        <tr>
+
                </tr>
          <td><a href="https://parts.igem.org/Part:BBa_K5237023" target="_blank">BBa_K5237023</a></td>
+
                <tr>
          <td>Oct1 - 5x UAS binding casette</td>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237019" target="_blank">BBa_K5237019</a></td>
          <td>Oct1 and UAS binding cassette, that was used for the simulated enhancer hijacking assay</td>
+
                    <td>TetR Binding Cassette</td>
        </tr>
+
                    <td>DNA sequence containing 12 Oct1 binding motifs, can be used for different assays such as the
        <tr>
+
                        FRET
          <td><a href="https://parts.igem.org/Part:BBa_K5237024" target="_blank">BBa_K5237024</a></td>
+
                        proximity assay</td>
          <td>TRE-minimal promoter- firefly luciferase</td>
+
                </tr>
          <td>Contains Firefly luciferase controlled by a minimal promoter. It was used as a luminescence readout for
+
                <td><a href="https://parts.igem.org/Part:BBa_K5237020" target="_blank">BBa_K5237020</a></td>
            simulated enhancer hijacking</td>
+
                <td>Cathepsin B-Cleavable <i>Trans</i>-Activator: NLS-Gal4-GFLG-VP64</td>
        </tr>
+
                <td>Readout system that responds to protease activity, which was used to test cathepsin B-cleavable
      </tbody>
+
                    linker
    </table>
+
                </td>
     </p>
+
                <tr>
  </section>
+
                    <td><a href="https://parts.igem.org/Part:BBa_K5237021" target="_blank">BBa_K5237021</a></td>
  <section id="1">
+
                    <td>NLS-Gal4-VP64</td>
    <h1>1. Sequence overview</h1>
+
                    <td><i>Trans</i>-activating enhancer, that can be used to simulate enhancer hijacking</td>
  </section>
+
                </tr>
 +
                <td><a href="https://parts.igem.org/Part:BBa_K5237022" target="_blank">BBa_K5237022</a></td>
 +
                <td>mCherry Expression Cassette: UAS, minimal Promoter, mCherry</td>
 +
                <td>Readout system for enhancer binding, which was used to test cathepsin B-cleavable linker</td>
 +
                <tr>
 +
                    <td><a href="https://parts.igem.org/Part:BBa_K5237023" target="_blank">BBa_K5237023</a></td>
 +
                    <td>Oct1 - 5x UAS Binding Casette</td>
 +
                    <td>Oct1 and UAS binding cassette, that was used for the simulated enhancer hijacking assay</td>
 +
                </tr>
 +
                <tr>
 +
                    <td><a href="https://parts.igem.org/Part:BBa_K5237024" target="_blank">BBa_K5237024</a></td>
 +
                    <td>TRE-minimal Promoter- Firefly Luciferase</td>
 +
                    <td>Contains firefly luciferase controlled by a minimal promoter, which was used as a luminescence
 +
                        readout for
 +
                        simulated enhancer hijacking</td>
 +
                </tr>
 +
            </tbody>
 +
        </table>
 +
     </section>
 +
    <section id="1">
 +
        <h1>1. Sequence Overview</h1>
 +
    </section>
 
</body>
 
</body>
  
 
</html>
 
</html>
 
 
<!--################################-->
 
<!--################################-->
<span class='h3bb'>Sequence and Features</span>
+
<span class="h3bb">Sequence and Features</span>
 
<partinfo>BBa_K5237024 SequenceAndFeatures</partinfo>
 
<partinfo>BBa_K5237024 SequenceAndFeatures</partinfo>
 
<!--################################-->
 
<!--################################-->
 
 
<html>
 
<html>
 
 
 
<section id="2">
 
<section id="2">
  <h1>2. Usage and Biology</h1>
+
    <h1>2. Usage and Biology</h1>
 
+
    <p>
  <p>
+
        The tetracycline response element, part of the TetR family of regulators (TFRs), is central to the regulation of
    The tetracycline response element, part of the TetR family of regulators (TFRs), is central to the regulation of
+
        antibiotic resistance genes, especially through its role in the Tet operon (TetO). In this system, the TetR
    antibiotic resistance genes, especially through its role in the Tet operon (TetO). In this system, the TetR protein
+
        protein
    acts
+
        acts
    as a repressor by binding to the TetO operator, inhibiting the expression of tetracycline resistance genes. Upon
+
        as a repressor by binding to the TetO operator, inhibiting the expression of tetracycline resistance genes. Upon
    binding
+
        binding
    tetracycline or its analogs, TetR undergoes a conformational change, releasing TetO and allowing the transcription
+
        tetracycline or its analogs, TetR undergoes a conformational change, releasing TetO and allowing the
    of
+
        transcription
    target genes. This system is widely utilized in molecular biology as a controlled gene expression tool, particularly
+
        of
    in
+
        target genes. This system is widely utilized in molecular biology as a controlled gene expression tool,
    inducible gene expression systems in both prokaryotic and eukaryotic cells (Cuthbertson and Nodwell (2013)).
+
        particularly
  </p>
+
        in
  <p>
+
        inducible gene expression systems in both prokaryotic and eukaryotic cells (Cuthbertson & Nodwell, 2013).
    Firefly luciferases are enzymes responsible for the bioluminescence seen in fireflies, catalyzing the oxidation of
+
    </p>
    luciferin in the presence of ATP, magnesium ions, and oxygen. This reaction produces light and is highly efficient,
+
    <p>
    with
+
        Firefly luciferases are enzymes responsible for the bioluminescence seen in fireflies, catalyzing the oxidation
    little heat released, making it a popular tool in molecular biology for reporter assays. The gene encoding firefly
+
        of
    luciferase is widely used in research to monitor gene expression, quantify cellular ATP levels, and study
+
        luciferin in the presence of ATP, magnesium ions, and oxygen. This reaction produces light and is highly
    transcriptional activity due to its sensitivity and ease of detection (Xie <i>et al.</i> (2010))
+
        efficient,
  </p>
+
        with
  <p>
+
        little heat released, making it a popular tool in molecular biology for reporter assays. The gene encoding
    We utilize the recognition site for plasmid to plasmid stapling with our Cas staples. A fgRNA targeting Tre and Oct1
+
        firefly
    on
+
        luciferase is widely used in research to monitor gene expression, quantify cellular ATP levels, and study
    the other plasmid, is the key factor in the Cas staple, bringing them together. When the transactivator, Gal4-VP64,
+
        transcriptional activity due to its sensitivity and ease of detection (Xie <i>et al.</i> (2010))
    binds as well we have transactivation as a readout for functioning staples.
+
    </p>
  </p>
+
    <p>
 +
        We utilize the recognition site for plasmid-to-plasmid stapling with our Cas staples. A fgRNA targeting Tre and
 +
        Oct1
 +
        on
 +
        the other plasmid, is the key factor in the Cas staple, bringing them together. When the transactivator,
 +
        Gal4-VP64,
 +
        binds as well we have transactivation as a readout for functioning staples.
 +
    </p>
 
</section>
 
</section>
 
<section id="3">
 
<section id="3">
  <h1>3. Assembly and part evolution</h1>
+
    <h1>3. Assembly and Part Evolution</h1>
  <p>
+
    <p>
    The cloning strategy designed for TetO allows for the easy assembly of repetitive repeats. It follows the procedure
+
        The cloning strategy designed for TetO allows for the easy assembly of repetitive repeats. It follows the
    outlined by Sladitschek and Neveu (2015). Briefly, the oligos can be inserted into a vector digested with SalI and
+
        procedure
    XhoI, yielding a vector with three binding repeats flanked by these restriction sites. The vector can be linearized
+
        outlined by Sladitschek and Neveu (2015). Briefly, the oligos can be inserted into a vector digested with SalI
    with either SalI or XhoI, as both enzymes create compatible overhangs. The annealed oligos can then be ligated into
+
        and
    the vector, resulting in six binding repeats, with the middle sequence losing its cleavage site compatibility. This
+
        XhoI, yielding a vector with three binding repeats flanked by these restriction sites. The vector can be
    process can be repeated to achieve the desired number of repeats by digesting the vector and re-ligating the oligos.
+
        linearized
    For the experiments conducted, a folding plasmid with 12 repeats was created. Since the registry has some
+
        with either SalI or XhoI, as both enzymes create compatible overhangs. The annealed oligos can then be ligated
    limitations regarding sequence depository, the binding cassette is flanked by SalI and XhoI, and the top and bottom
+
        into
    oligos with the fitting overhangs are annotated.
+
        the vector, resulting in six binding repeats, with the middle sequence losing its cleavage site compatibility.
  </p>
+
        This
 +
        process can be repeated to achieve the desired number of repeats by digesting the vector and re-ligating the
 +
        oligos.
 +
        For the experiments conducted, a folding plasmid with 12 repeats was created. Since the registry has some
 +
        limitations regarding sequence depository, the binding cassette is flanked by SalI and XhoI, and the top and
 +
        bottom
 +
        oligos with the fitting overhangs are annotated.
 +
    </p>
 
</section>
 
</section>
 
<section id="4">
 
<section id="4">
  <h1>4. Results</h1>
+
    <h1>4. Results</h1>
  <p>
+
    <p>
    We were able to show our enhancer plasmid to work great with the Cas staples and the reporter plasmid. For the whole
+
        We were able to show our enhancer plasmid to work great with the Cas staples and the reporter plasmid. For the
    assay, an enhancer plasmid and the reporter plasmid was used. The reporter plasmid has firefly luciferase behind
+
        whole
    several repeats of a Cas9 targeted sequence. The enhancer plasmid has the Oct1 being targeted by Cas12a. By
+
        assay, an enhancer plasmid and the reporter plasmid were used. The reporter plasmid has firefly luciferase
    introducing a fgRNA staple (<a href="https://parts.igem.org/PArt:BBa_K5237000">BBa_K5237000</a>) and a Gal4-VP64 (<a
+
        behind
      href="https://parts.igem.org/PArt:BBa_K5237021">BBa_K5237021</a>), expression of the luciferase is induced
+
        several repeats of a Cas9 targeted sequence. The enhancer plasmid has the Oct1 being targeted by Cas12a. By
    (Fig. 2 A).
+
        introducing a fgRNA staple (<a href="https://parts.igem.org/PArt:BBa_K5237000">BBa_K5237000</a>) and a Gal4-VP64
    Cells were again normalized against ubiquitous renilla expression.
+
        (<a href="https://parts.igem.org/PArt:BBa_K5237021">BBa_K5237021</a>), expression of the luciferase is induced
    Using no linker between the two spacers showed similar relative luciferase activity to the baseline control (Fig. 2 B). An extension of the linker from 20 nt up to 40 nt resulted in an increasingly higher
+
        (Fig. 2A).
    expression of the reporter gene. These results suggest an extension of the linker might lead to better
+
        Cells were again normalized against ubiquitous renilla expression.
    transactivation when hijacking an enhancer/activator.
+
        Using no linker between the two spacers showed similar relative luciferase activity to the baseline control
  </p>
+
        (Fig. 2B). An extension of the linker from 20 nt up to 40 nt resulted in an increasingly higher
  <div class="thumb">
+
        expression of the reporter gene. These results suggest an extension of the linker might lead to better
    <div class="thumbinner" style="width:60%;">
+
        transactivation when hijacking an enhancer/activator.
      <img alt="" class="thumbimage" src="https://static.igem.wiki/teams/5237/wetlab-results/results-eh-2.svg"
+
    </p>
        style="width:99%;" />
+
    <div class="thumb">
      <div class="thumbcaption">
+
        <div class="thumbinner" style="width:60%;">
        <i>
+
            <img alt="" class="thumbimage" src="https://static.igem.wiki/teams/5237/wetlab-results/results-eh-2.svg"
          <b>Figure 2: Applying Fusion Guide RNAs for Cas staples.</b> <b>A</b>, schematic overview of the assay.
+
                style="width:99%;" />
          An enhancer
+
            <div class="thumbcaption">
          plasmid and a reporter plasmid are brought into proximity by a fgRNA Cas staple complex binding both
+
                <i>
          plasmids. Target
+
                    <b>Figure 2: Applying Fusion Guide RNAs for Cas staples.</b> <b>A</b>, schematic overview of the
          sequences were included in multiple repeats prior to the functional elements. Firefly luciferase serves as
+
                    assay.
          the reporter
+
                    An enhancer
          gene, the enhancer is constituted by multiple Gal4 repeats that are bound by a Gal4-VP64 fusion.
+
                    plasmid and a reporter plasmid are brought into proximity by an fgRNA Cas staple complex binding
          <b>B</b>, results of using a fgRNA Cas staple for trans activation of firefly luciferase. Firefly
+
                    both
          luciferase activity was measured 48h after transfection. Normalized against ubiquitously expressed Renilla
+
                    plasmids. Target
          luciferase.
+
                    sequences were included in multiple repeats prior to the functional elements. Firefly luciferase
          Statistical significance was calculated with ordinary One-way ANOVA with Dunn's method for multiple
+
                    serves as
          comparisons (*p &lt;
+
                    the reporter
          0.05; **p &lt; 0.01; ***p &lt; 0.001; mean +/- SD). The assay included sgRNAs and fgRNAs with linker
+
                    gene, the enhancer is constituted by multiple Gal4 repeats that are bound by a Gal4-VP64 fusion.
          lengths from 0 nt
+
                    <b>B</b>, results of using a fgRNA Cas staple for trans activation of firefly luciferase. Firefly
          to 40 nt.
+
                    luciferase activity was measured 48h after transfection. Normalized against ubiquitously expressed
        </i>
+
                    Renilla
      </div>
+
                    luciferase.
 +
                    Statistical significance was calculated with ordinary One-way ANOVA with Dunn's method for multiple
 +
                    comparisons (*p &lt;
 +
                    0.05; **p &lt; 0.01; ***p &lt; 0.001; mean +/- SD). The assay included sgRNAs and fgRNAs with linker
 +
                    lengths from 0 nt
 +
                    to 40 nt.
 +
                </i>
 +
            </div>
 +
        </div>
 
     </div>
 
     </div>
  </div>
 
 
</section>
 
</section>
 
<section id="5">
 
<section id="5">
  <h1>5. References</h1>
+
    <h1>5. <i>In Silico</i> Characterization using DaVinci</h1>
   <p>Wu, W., Zhang, L., Yao, L., Tan, X., Liu, X., & Lu, X. (2015). Genetically assembled fluorescent biosensor
+
            <p>
    for in situ detection of bio-synthesized alkanes. Scientific reports, 5, 10907. <a
+
                We developed the <i>in silico</i> model <a href="https://2024.igem.wiki/heidelberg/model" target="_blank">DaVinci</a> for rapid engineering and development of our PICasSO
      href="https://doi.org/10.1038/srep10907" target="_blank">https://doi.org/10.1038/srep10907</a></p>
+
                system. DaVinci acts as a digital twin to PICasSO, designed to understand the forces acting on our
 +
                system, refine experimental parameters, and find optimal connections between protein staples and
 +
                target DNA.<br>
 +
                We calibrated DaVinci with literature and our own experimental affinity data obtained via EMSA
 +
                assays and purified proteins. This enabled us to simulate enhancer hijacking <i>in silico</i>, providing
 +
                valuable input for the design of further experiments. Additionally, we apply the same approach to
 +
                our part collection. <br><br>
 +
                DaVinci is divided into three phases: static structure prediction, all-atom dynamics simulation, and
 +
                long-ranged dna dynamics simulation. Here, we applied the last step to our parts, characterizing
 +
                structure and dynamics of the dna-binding interaction.
 +
            </p>
 +
            <section id="5.1">
 +
                <h2>5.1. Enhancer Hijacking is Successfully Studied <I>In Silico</i></h2>
 +
                        <div class="thumb tright" style="margin:0;">
 +
                            <div class="thumbinner" style="width:300px;">
 +
                                <img src="https://static.igem.wiki/teams/5237/figures-corrected/drylab-plasmids-cas-staple-fgrna.svg"
 +
                                    class="thumbimage" style="width:99%;">
 +
                                <div class="thumbcaption">
 +
                                    <i>
 +
                                        <b>Figure 11: Cas stapled plasmids.</b>
 +
                                    </i>
 +
                                </div>
 +
                            </div>
 +
                        </div>
 +
                        <p>
 +
                            With the Cas staple, we aimed to simulate the principles of enhancer hijacking
 +
                            experiments we
 +
                            conducted in the lab. For these experiments, we modeled the two plasmids also used in
 +
                            the wet lab
 +
                            (<a href="https://parts.igem.org/Part:BBa_K5237023" target="_blank">BBa_K5237023</a> and
 +
                            <a href="https://parts.igem.org/Part:BBa_K5237024" target="_blank">BBa_K5237024</a>). On
 +
                            top of the
 +
                            two plasmids, we modeled the Cas staple by applying a “DNA-DNA tethering force"
 +
                            throughout our
 +
                            simulation, selectively on the regions targeted by the fgRNA. This force was based on
 +
                            simulation
 +
                            data acquired in earlier phases of DaVinci. As there is no suitable model available that
 +
                            also
 +
                            simulates proteins, this proved to be the most effective modeling strategy.
 +
                        </p>
 +
    
 +
                        <p>
 +
                            Our simulation showed the expected behavior, holding the target sequences of the Cas
 +
                            staple (Fig. 12).
 +
                            Overall, these exciting results demonstrate that we can successfully model the core
 +
                            principles of
 +
                            enhancer hijacking with a total of 20 thousand simulated nucleotides <i>in silico</i>.
 +
                        </p>
 +
 
 +
                        <div class="thumb" style="width:50%;">
 +
                            <div class="thumbinner" style="position:center; padding-bottom:56.25%; height:257px;">
 +
                                <iframe title="Heidelberg: predicted_fgRNA_long_slow (2024)"
 +
                                    src="https://video.igem.org/videos/embed/db213b54-039e-42ca-aa29-c70614172e49?title=0&amp;warningTitle=0"
 +
                                    frameborder="0" allowfullscreen="" sandbox="allow-same-origin allow-scripts allow-popups allow-forms"
 +
                                    style="width:100%; height:100%;"
 +
                                    class="thumbimage">
 +
                                </iframe>
 +
                            </div>
 +
                            <div class="thumbcaption">
 +
                            <i>
 +
                                <b>Figure 12: Fusion Cas staples hold stapled nucleotides in close proximity.</b>
 +
                            </i>
 +
                            </div>
 +
                        </div>
 +
            </section>
 +
 
 +
            <section id="5.2">
 +
                <h2>5.2. Cas staple Forces Do Not Distrub DNA Strand Integrity</h2>
 +
                <div class="thumb tright">
 +
                    <div class="thumbinner" style="width:300px;">
 +
                        <img src="https://static.igem.wiki/teams/5237/figures-corrected/drylab-plasmids-cas-staple-fgrna.svg"
 +
                            class="thumbimage" style="width:99%;">
 +
                        <div class="thumbcaption">
 +
                            <i>
 +
                                <b>Figure 13: Cas stapled plasmids.</b>
 +
                            </i>
 +
                        </div>
 +
                    </div>
 +
                </div>
 +
                <p>
 +
                    Next, we aimed to stress test our system to determine the amount of force required to induce DNA
 +
                    double-strand breaks. To achieve this, we used an identical setup to the previous experiment but
 +
                    instead of
 +
                    experimentally determined forces, we used artificial forces of varying strength.
 +
                    It is important to know that our <i>in silico</i> model responds to forces that cause double-strand
 +
                    breaks by
 +
                    scattering the nucleotides across the simulation box. As the specified bonds cannot actually
 +
                    break within
 +
                    the simulation, the phosphate backbone bonds become severely distorted and exhibit erratic
 +
                    behavior in the
 +
                    simulation videos. From our extensive simulations, we concluded that the forces required to damage the DNA are approximately 320 times (Fig. 15) and 680 times greater (Fig. 16) than the forces exerted by the Cas staple, respectively.
 +
                    <br><br>
 +
                    This provides important evidence regarding
 +
                    the safety of
 +
                    our staple approach for 3D genome engineering: According to our model, DNA-DNA tethering with
 +
                    our Cas
 +
                    staples is not expected to have a negative effect on the DNA stability.
 +
                </p>
 +
               
 +
 
 +
                  <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 10px; overflow: auto;">
 +
                      <!-- First Video -->
 +
                      <div class="thumb">
 +
                          <div class="thumbinner">
 +
                              <iframe title="Heidelberg: fgRNA_neg_272x_slow (2024)" src="https://video.igem.org/videos/embed/7ea11707-ace8-44b0-9b6a-6e623474bc0a?title=0&warningTitle=0" allowfullscreen="" sandbox="allow-same-origin allow-scripts allow-popups allow-forms" style="width: 100%; aspect-ratio: 16/9;"></iframe>
 +
                          </div>
 +
                          <div class="thumbcaption">
 +
                              <i><b>Figure 14: Applying a force that is 270 times greater <br> than the predicted force typically exerted by a Cas staple on DNA.</b></i>
 +
                          </div>
 +
                      </div>
 +
                 
 +
                      <!-- Second Video -->
 +
                      <div class="thumb">
 +
                          <div class="thumbinner">
 +
                              <iframe title="Heidelberg: fgRNA_neg_318x_slow (2024)" src="https://video.igem.org/videos/embed/66db402a-c94a-4aad-b30b-386b8ccc20b0?title=0&warningTitle=0" allowfullscreen="" sandbox="allow-same-origin allow-scripts allow-popups allow-forms" style="width: 100%; aspect-ratio: 16/9;"></iframe>
 +
                          </div>
 +
                          <div class="thumbcaption">
 +
                              <i><b>Figure 15: Applying a force that is 320 times greater <br> than the predicted force typically exerted by a Cas staple on DNA.</b></i>
 +
                          </div>
 +
                      </div>
 +
                 
 +
                      <!-- Third Video -->
 +
                      <div class="thumb">
 +
                          <div class="thumbinner">
 +
                              <iframe title="Heidelberg: fgRNA_neg_681x_slow (2024)" src="https://video.igem.org/videos/embed/5e6240ab-1057-4db6-a992-22a17d2fcc55?title=0&warningTitle=0" allowfullscreen="" sandbox="allow-same-origin allow-scripts allow-popups allow-forms" style="width: 100%; aspect-ratio: 16/9;"></iframe>
 +
                          </div>
 +
                          <div class="thumbcaption">
 +
                              <i><b>Figure 16: Applying a force that is 680 times greater <br> than the predicted force typically exerted by a Cas staple on DNA.</b></i>
 +
                          </div>
 +
                      </div>
 +
                 
 +
                      <!-- Fourth Video -->
 +
                      <div class="thumb">
 +
                          <div class="thumbinner">
 +
                              <iframe title="Heidelberg: fgRNA_neg_1000x_slow (2024)" src="https://video.igem.org/videos/embed/26f9ba1c-51b9-4931-b1d3-8129ff3a57a7?title=0&warningTitle=0" allowfullscreen="" sandbox="allow-same-origin allow-scripts allow-popups allow-forms" style="width: 100%; aspect-ratio: 16/9;"></iframe>
 +
                          </div>
 +
                          <div class="thumbcaption">
 +
                              <i><b>Figure 17: Applying a force that is more than 1000 times greater <br> than the predicted force typically exerted by a Cas staple on DNA.</b></i>
 +
                          </div>
 +
                      </div>
 +
                  </div>
 +
            </section>
 +
 
 +
            <section id="5.3">
 +
                <h2>5.3. DaVinci Helps to Design Multi-Staple Arrangements</h2>
 +
 
 +
                <div class="thumb tright">
 +
                    <div class="thumbinner" style="width:300px;">
 +
                        <img src="https://static.igem.wiki/teams/5237/figures-corrected/drylab-plasmids-multiplexing-broken-cas-staple-fgrna-correct.svg"
 +
                            class="thumbimage" style="width:99%;">
 +
                        <div class="thumbcaption">
 +
                            <i>
 +
                                <b>Figure 18: Double Cas stapling within 40 nucleotide distance induces
 +
                                    double-strand
 +
                                    breaks.</b>
 +
                            </i>
 +
                        </div>
 +
                    </div>
 +
                </div>
 +
                <p>
 +
                    Finally, we simulated the behavior of multiple staples at once. Therefore, we expanded our
 +
                    previously
 +
                    introduced experimental setup by a second Cas staple.<br>
 +
                    In a first approach, we targeted an additional region next to the original chosen one. This
 +
                    region is 40
 +
                    nucleotides away from the first target region on the plasmid displayed in blue connecting it to
 +
                    the opposite
 +
                    site of the orange plasmid, therefore bringing both ends of the orange plasmid together (Fig. 18).<br>
 +
                    Our simulation predicted that with these staple points, DNA double-strand breaks would occur as clearly visible by the scattered nucleotides (Fig. 19).
 +
                </p>
 +
 
 +
 
 +
 
 +
 
 +
                <div class="thumb" style="width:50%;">
 +
                    <div class="thumbinner" style="position:center; padding-bottom:56.25%; height:257px;">
 +
                        <iframe title="Heidelberg: multiplex_pos_40nt_slow (2024)"
 +
                            src="https://video.igem.org/videos/embed/2d153686-202b-414f-9abd-20835110953c?title=0&amp;warningTitle=0"
 +
                            frameborder="0" allowfullscreen="" sandbox="allow-same-origin allow-scripts allow-popups allow-forms"
 +
                            style="width:100%; height:100%;"
 +
                            class="thumbimage">
 +
                        </iframe>
 +
                    </div>
 +
                    <div class="thumbcaption">
 +
                    <i>
 +
                        <b>Figure 19: Double Cas stapling within 40 nucleotide distance induces
 +
                            double-strand
 +
                            breaks.</b>
 +
                    </i>
 +
                    </div>
 +
                </div>
 +
 
 +
 
 +
                <div class="thumb tright">
 +
                    <div class="thumbinner" style="width:300px;">
 +
                        <img  src="https://static.igem.wiki/teams/5237/figures-corrected/drylab-plasmids-multiplexing-notbroken-cas-staple-fgrna-correct2.svg"
 +
                            class="thumbimage" style="width:99%;">
 +
                        <div class="thumbcaption">
 +
                            <i>
 +
                                <b>Figure 20: Stable multiplexing with 2 Cas staples.</b> On the blue plasmid, the
 +
                                Cas binding
 +
                                sequences are 980 nucleotides apart.</b>
 +
                            </i>
 +
                        </div>
 +
                    </div>
 +
                </div>
 +
 
 +
                <p>
 +
                    To simulate a setup where we expect no double-strand breaks, we increased the distance between
 +
                    the stapling
 +
                    sites on the blue plasmid (<a href="https://parts.igem.org/Part:BBa_K5237023"
 +
                        target="_blank">BBa_K5237023</a>) from 40 to 980 nucleotides (Fig. 20).<br>
 +
                    With this increased distance between stapling sites, we observed a stabilized system. Most
 +
                    interestingly,
 +
                    the non-stapled regions showed maximum distances close to 500 nm, indicating that the two
 +
                    staples led to
 +
                    more compact plasmid structures.
 +
                    <br><br>
 +
                    In conclusion, we show that applying multiple staples on the same structures can lead to
 +
                    double-strand
 +
                    breaks if the staples are positioned closely to one another. However, increasing the separation
 +
                    of staples
 +
                    leads to a stable system without DNA damage. Thus, it is definitely possible to multiplex Cas
 +
                    staples,
 +
                    thereby increasing the compactness of DNA structures (Fig. 21). This shows the potential of creating
 +
                    complex
 +
                    regulatory networks by bringing genetic elements into spatial proximity with a multitude of Cas
 +
                    protein
 +
                    staples.
 +
                </p>
 +
 
 +
 
 +
                <div class="thumb" style="width:50%;">
 +
                    <div class="thumbinner" style="position:center; padding-bottom:56.25%; height:257px;">
 +
                        <iframe title="Heidelberg: multiplex_pos_980nt_slow (2024)"
 +
                            src="https://video.igem.org/videos/embed/777bd304-e6a0-4457-9f57-29637b7b5436?title=0&amp;warningTitle=0"
 +
                            frameborder="0" allowfullscreen="" sandbox="allow-same-origin allow-scripts allow-popups allow-forms"
 +
                            style="width:100%; height:100%;"
 +
                            class="thumbimage">
 +
                        </iframe>
 +
                    </div>
 +
                    <div class="thumbcaption">
 +
                    <i>
 +
                        <b>Figure 21: Increasing the distance between Cas staple targets to 980 nucleotides
 +
                            stabilizes
 +
                            multiplexing.</b>
 +
                    </i>
 +
                    </div>
 +
                </div>
 +
            </section>
 +
  </section>
 +
<section id="6">
 +
    <h1>6. References</h1>
 +
    <p>Wu, W., Zhang, L., Yao, L., Tan, X., Liu, X., &amp; Lu, X. (2015). Genetically assembled fluorescent biosensor
 +
        for in situ detection of bio-synthesized alkanes. Scientific reports, 5, 10907. <a
 +
            href="https://doi.org/10.1038/srep10907" target="_blank">https://doi.org/10.1038/srep10907</a></p>
 
</section>
 
</section>
</body>
 
  
 
</html>
 
</html>

Latest revision as of 12:56, 2 October 2024

BBa_K5237024

TRE-minimal Promoter - Firefly Luciferase

This part contains the tetO binding site (BBa_K5237019), a minimal promoter and a firefly luciferase gene. With a VP64 coming in close proximity to the minimal promoter transcription factors are recruited, initiating expression of firefly luciferase. The described mechanism is utilized in our enhancer hijacking assay for prove of Cas stapling.



The PICasSO Toolbox
Figure 1: How our part collection can be used to engineer new staples


While synthetic biology has in the past focused on engineering the genomic sequence of organisms, the 3D spatial organization of DNA is well-known to be an important layer of information encoding in particular in eukaryotes, playing a crucial role in gene regulation and hence cell fate, disease development, evolution, and more. However, tools to precisely manipulate and control the genomic spatial architecture are limited, hampering the exploration of 3D genome engineering in synthetic biology. We - the iGEM Team Heidelberg 2024 - have developed PICasSO, a powerful molecular toolbox for rationally engineering genome 3D architectures in living cells, based on various DNA-binding proteins.

The PICasSO part collection offers a comprehensive, modular platform for precise manipulation and re-programming of DNA-DNA interactions using engineered "protein staples" in living cells. This enables researchers to recreate naturally occurring alterations of 3D genomic interactions, such as enhancer hijacking in cancer, or to design entirely new spatial architectures for artificial gene regulation and cell function control. Specifically, the fusion of two DNA binding proteins enables to artificially bring otherwise distant genomic loci into spatial proximity. To unlock the system's full potential, we introduce versatile chimeric CRISPR/Cas complexes, connected either at the protein or - in the case of CRISPR/Cas-based DNA binding moieties - the guide RNA level. These complexes are referred to as protein- or Cas staples, respectively. Beyond its versatility with regard to the staple constructs themselves, PICasSO includes robust assay systems to support the engineering, optimization, and testing of new staples in vitro and in vivo. Notably, the PICasSO toolbox was developed in a design-build-test-learn engineering cycle closely intertwining wet lab experiments and computational modeling and iterated several times, yielding a collection of well-functioning and -characterized parts.

At its heart, the PICasSO part collection consists of three categories.
(i) Our DNA-binding proteins include our finalized Cas staple experimentally validated using an artificial "enhancer hijacking" system as well as "half staples" that can be combined by scientists to compose entirely new Cas staples in the future. We also include our Simple staples comprised of particularly small, simple and robust DNA binding domains well-known to the synthetic biology community, which serve as controls for successful stapling and can be further engineered to create alternative, simpler, and more compact staples.
(ii) As functional elements, we list additional parts that enhance and expand the functionality of our Cas and Basic staples. These consist of staples dependent on cleavable peptide linkers targeted by cancer-specific proteases or inteins that allow condition-specific, dynamic stapling in vivo. We also include several engineered parts that enable the efficient delivery of PICasSO's constructs into target cells, including mammalian cells, with our new interkingdom conjugation system.
(iii) As the final category of our collection, we provide parts that underlie our custom readout systems. These include components of our established FRET-based proximity assay system, enabling users to confirm accurate stapling. Additionally, we offer a complementary, application-oriented testing system based on a luciferase reporter, which allows for straightforward experimental assessment of functional enhancer hijacking events in mammalian cells.

The following table gives a comprehensive overview of all parts in our PICasSO toolbox. The highlighted parts showed exceptional performance as described on our iGEM wiki and can serve as a reference. The other parts in the collection are versatile building blocks designed to provide future iGEMers with the flexibility to engineer their own custom Cas staples, enabling further optimization and innovation in the new field of 3D genome engineering.

Our part collection includes:

DNA-Binding Proteins: Modular building blocks for engineering of custom staples to mediate defined DNA-DNA interactions in vivo
BBa_K5237000 Fusion Guide RNA Entry Vector MbCas12a-SpCas9 Entry vector for simple fgRNA cloning via SapI
BBa_K5237001 Staple Subunit: dMbCas12a-Nucleoplasmin NLS Staple subunit that can be combined with crRNA or fgRNA and dSpCas9 to form a functional staple
BBa_K5237002 Staple Subunit: SV40 NLS-dSpCas9-SV40 NLS Staple subunit that can be combined with a sgRNA or fgRNA and dMbCas12a to form a functional staple
BBa_K5237003 Cas Staple: SV40 NLS-dMbCas12a-dSpCas9-Nucleoplasmin NLS Functional Cas staple that can be combined with sgRNA and crRNA or fgRNA to bring two DNA strands into close proximity
BBa_K5237004 Staple Subunit: Oct1-DBD Staple subunit that can be combined to form a functional staple, for example with TetR.
Can also be combined with a fluorescent protein as part of the FRET proximity assay
BBa_K5237005 Staple Subunit: TetR Staple subunit that can be combined to form a functional staple, for example with Oct1.
Can also be combined with a fluorescent protein as part of the FRET proximity assay
BBa_K5237006 Simple Staple: TetR-Oct1 Functional staple that can be used to bring two DNA strands in close proximity
BBa_K5237007 Staple Subunit: GCN4 Staple subunit that can be combined to form a functional staple, for example with rGCN4
BBa_K5237008 Staple Subunit: rGCN4 Staple subunit that can be combined to form a functional staple, for example with rGCN4
BBa_K5237009 Mini Staple: bGCN4 Assembled staple with minimal size that can be further engineered
Functional Elements: Protease-cleavable peptide linkers and inteins are used to control and modify staples for further optimization for custom applications
BBa_K5237010 Cathepsin B-cleavable Linker: GFLG Cathepsin B-cleavable peptide linker that can be used to combine two staple subunits to make responsive staples
BBa_K5237011 Cathepsin B Expression Cassette Expression cassette for the overexpression of cathepsin B
BBa_K5237012 Caged NpuN Intein A caged NpuN split intein fragment that undergoes protein trans-splicing after protease activation, which can be used to create functionalized staple subunits
BBa_K5237013 Caged NpuC Intein A caged NpuC split intein fragment that undergoes protein trans-splicing after protease activation, which can be used to create functionalized staple subunits
BBa_K5237014 Fusion Guide RNA Processing Casette Processing cassette to produce multiple fgRNAs from one transcript, that can be used for multiplexed 3D genome reprogramming
BBa_K5237015 Intimin anti-EGFR Nanobody Interkingdom conjugation between bacteria and mammalian cells, as an alternative delivery tool for large constructs
BBa_K4643003 IncP Origin of Transfer Origin of transfer that can be cloned into the plasmid vector and used for conjugation as a means of delivery
Readout Systems: FRET and enhancer recruitment readout systems to rapidly assess successful DNA stapling in bacterial and mammalian cells
BBa_K5237016 FRET-Donor: mNeonGreen-Oct1 FRET donor-fluorophore fused to Oct1-DBD that binds to the Oct1 binding cassette, which can be used to visualize DNA-DNA proximity
BBa_K5237017 FRET-Acceptor: TetR-mScarlet-I Acceptor part for the FRET assay binding the TetR binding cassette, which can be used to visualize DNA-DNA proximity
BBa_K5237018 Oct1 Binding Casette DNA sequence containing 12 Oct1 binding motifs, compatible with various assays such as the FRET proximity assay
BBa_K5237019 TetR Binding Cassette DNA sequence containing 12 Oct1 binding motifs, can be used for different assays such as the FRET proximity assay
BBa_K5237020 Cathepsin B-Cleavable Trans-Activator: NLS-Gal4-GFLG-VP64 Readout system that responds to protease activity, which was used to test cathepsin B-cleavable linker
BBa_K5237021 NLS-Gal4-VP64 Trans-activating enhancer, that can be used to simulate enhancer hijacking
BBa_K5237022 mCherry Expression Cassette: UAS, minimal Promoter, mCherry Readout system for enhancer binding, which was used to test cathepsin B-cleavable linker
BBa_K5237023 Oct1 - 5x UAS Binding Casette Oct1 and UAS binding cassette, that was used for the simulated enhancer hijacking assay
BBa_K5237024 TRE-minimal Promoter- Firefly Luciferase Contains firefly luciferase controlled by a minimal promoter, which was used as a luminescence readout for simulated enhancer hijacking

1. Sequence Overview

Sequence and Features


Assembly Compatibility:
  • 10
    INCOMPATIBLE WITH RFC[10]
    Illegal EcoRI site found at 99
    Illegal XbaI site found at 61
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal EcoRI site found at 99
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal EcoRI site found at 99
    Illegal BamHI site found at 78
    Illegal XhoI site found at 48
  • 23
    INCOMPATIBLE WITH RFC[23]
    Illegal EcoRI site found at 99
    Illegal XbaI site found at 61
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal EcoRI site found at 99
    Illegal XbaI site found at 61
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal SapI.rc site found at 952

2. Usage and Biology

The tetracycline response element, part of the TetR family of regulators (TFRs), is central to the regulation of antibiotic resistance genes, especially through its role in the Tet operon (TetO). In this system, the TetR protein acts as a repressor by binding to the TetO operator, inhibiting the expression of tetracycline resistance genes. Upon binding tetracycline or its analogs, TetR undergoes a conformational change, releasing TetO and allowing the transcription of target genes. This system is widely utilized in molecular biology as a controlled gene expression tool, particularly in inducible gene expression systems in both prokaryotic and eukaryotic cells (Cuthbertson & Nodwell, 2013).

Firefly luciferases are enzymes responsible for the bioluminescence seen in fireflies, catalyzing the oxidation of luciferin in the presence of ATP, magnesium ions, and oxygen. This reaction produces light and is highly efficient, with little heat released, making it a popular tool in molecular biology for reporter assays. The gene encoding firefly luciferase is widely used in research to monitor gene expression, quantify cellular ATP levels, and study transcriptional activity due to its sensitivity and ease of detection (Xie et al. (2010))

We utilize the recognition site for plasmid-to-plasmid stapling with our Cas staples. A fgRNA targeting Tre and Oct1 on the other plasmid, is the key factor in the Cas staple, bringing them together. When the transactivator, Gal4-VP64, binds as well we have transactivation as a readout for functioning staples.

3. Assembly and Part Evolution

The cloning strategy designed for TetO allows for the easy assembly of repetitive repeats. It follows the procedure outlined by Sladitschek and Neveu (2015). Briefly, the oligos can be inserted into a vector digested with SalI and XhoI, yielding a vector with three binding repeats flanked by these restriction sites. The vector can be linearized with either SalI or XhoI, as both enzymes create compatible overhangs. The annealed oligos can then be ligated into the vector, resulting in six binding repeats, with the middle sequence losing its cleavage site compatibility. This process can be repeated to achieve the desired number of repeats by digesting the vector and re-ligating the oligos. For the experiments conducted, a folding plasmid with 12 repeats was created. Since the registry has some limitations regarding sequence depository, the binding cassette is flanked by SalI and XhoI, and the top and bottom oligos with the fitting overhangs are annotated.

4. Results

We were able to show our enhancer plasmid to work great with the Cas staples and the reporter plasmid. For the whole assay, an enhancer plasmid and the reporter plasmid were used. The reporter plasmid has firefly luciferase behind several repeats of a Cas9 targeted sequence. The enhancer plasmid has the Oct1 being targeted by Cas12a. By introducing a fgRNA staple (BBa_K5237000) and a Gal4-VP64 (BBa_K5237021), expression of the luciferase is induced (Fig. 2A). Cells were again normalized against ubiquitous renilla expression. Using no linker between the two spacers showed similar relative luciferase activity to the baseline control (Fig. 2B). An extension of the linker from 20 nt up to 40 nt resulted in an increasingly higher expression of the reporter gene. These results suggest an extension of the linker might lead to better transactivation when hijacking an enhancer/activator.

Figure 2: Applying Fusion Guide RNAs for Cas staples. A, schematic overview of the assay. An enhancer plasmid and a reporter plasmid are brought into proximity by an fgRNA Cas staple complex binding both plasmids. Target sequences were included in multiple repeats prior to the functional elements. Firefly luciferase serves as the reporter gene, the enhancer is constituted by multiple Gal4 repeats that are bound by a Gal4-VP64 fusion. B, results of using a fgRNA Cas staple for trans activation of firefly luciferase. Firefly luciferase activity was measured 48h after transfection. Normalized against ubiquitously expressed Renilla luciferase. Statistical significance was calculated with ordinary One-way ANOVA with Dunn's method for multiple comparisons (*p < 0.05; **p < 0.01; ***p < 0.001; mean +/- SD). The assay included sgRNAs and fgRNAs with linker lengths from 0 nt to 40 nt.

5. In Silico Characterization using DaVinci

We developed the in silico model DaVinci for rapid engineering and development of our PICasSO system. DaVinci acts as a digital twin to PICasSO, designed to understand the forces acting on our system, refine experimental parameters, and find optimal connections between protein staples and target DNA.
We calibrated DaVinci with literature and our own experimental affinity data obtained via EMSA assays and purified proteins. This enabled us to simulate enhancer hijacking in silico, providing valuable input for the design of further experiments. Additionally, we apply the same approach to our part collection.

DaVinci is divided into three phases: static structure prediction, all-atom dynamics simulation, and long-ranged dna dynamics simulation. Here, we applied the last step to our parts, characterizing structure and dynamics of the dna-binding interaction.

5.1. Enhancer Hijacking is Successfully Studied In Silico

Figure 11: Cas stapled plasmids.

With the Cas staple, we aimed to simulate the principles of enhancer hijacking experiments we conducted in the lab. For these experiments, we modeled the two plasmids also used in the wet lab (BBa_K5237023 and BBa_K5237024). On top of the two plasmids, we modeled the Cas staple by applying a “DNA-DNA tethering force" throughout our simulation, selectively on the regions targeted by the fgRNA. This force was based on simulation data acquired in earlier phases of DaVinci. As there is no suitable model available that also simulates proteins, this proved to be the most effective modeling strategy.

Our simulation showed the expected behavior, holding the target sequences of the Cas staple (Fig. 12). Overall, these exciting results demonstrate that we can successfully model the core principles of enhancer hijacking with a total of 20 thousand simulated nucleotides in silico.

Figure 12: Fusion Cas staples hold stapled nucleotides in close proximity.

5.2. Cas staple Forces Do Not Distrub DNA Strand Integrity

Figure 13: Cas stapled plasmids.

Next, we aimed to stress test our system to determine the amount of force required to induce DNA double-strand breaks. To achieve this, we used an identical setup to the previous experiment but instead of experimentally determined forces, we used artificial forces of varying strength. It is important to know that our in silico model responds to forces that cause double-strand breaks by scattering the nucleotides across the simulation box. As the specified bonds cannot actually break within the simulation, the phosphate backbone bonds become severely distorted and exhibit erratic behavior in the simulation videos. From our extensive simulations, we concluded that the forces required to damage the DNA are approximately 320 times (Fig. 15) and 680 times greater (Fig. 16) than the forces exerted by the Cas staple, respectively.

This provides important evidence regarding the safety of our staple approach for 3D genome engineering: According to our model, DNA-DNA tethering with our Cas staples is not expected to have a negative effect on the DNA stability.

Figure 14: Applying a force that is 270 times greater
than the predicted force typically exerted by a Cas staple on DNA.
Figure 15: Applying a force that is 320 times greater
than the predicted force typically exerted by a Cas staple on DNA.
Figure 16: Applying a force that is 680 times greater
than the predicted force typically exerted by a Cas staple on DNA.
Figure 17: Applying a force that is more than 1000 times greater
than the predicted force typically exerted by a Cas staple on DNA.

5.3. DaVinci Helps to Design Multi-Staple Arrangements

Figure 18: Double Cas stapling within 40 nucleotide distance induces double-strand breaks.

Finally, we simulated the behavior of multiple staples at once. Therefore, we expanded our previously introduced experimental setup by a second Cas staple.
In a first approach, we targeted an additional region next to the original chosen one. This region is 40 nucleotides away from the first target region on the plasmid displayed in blue connecting it to the opposite site of the orange plasmid, therefore bringing both ends of the orange plasmid together (Fig. 18).
Our simulation predicted that with these staple points, DNA double-strand breaks would occur as clearly visible by the scattered nucleotides (Fig. 19).

Figure 19: Double Cas stapling within 40 nucleotide distance induces double-strand breaks.
Figure 20: Stable multiplexing with 2 Cas staples. On the blue plasmid, the Cas binding sequences are 980 nucleotides apart.

To simulate a setup where we expect no double-strand breaks, we increased the distance between the stapling sites on the blue plasmid (BBa_K5237023) from 40 to 980 nucleotides (Fig. 20).
With this increased distance between stapling sites, we observed a stabilized system. Most interestingly, the non-stapled regions showed maximum distances close to 500 nm, indicating that the two staples led to more compact plasmid structures.

In conclusion, we show that applying multiple staples on the same structures can lead to double-strand breaks if the staples are positioned closely to one another. However, increasing the separation of staples leads to a stable system without DNA damage. Thus, it is definitely possible to multiplex Cas staples, thereby increasing the compactness of DNA structures (Fig. 21). This shows the potential of creating complex regulatory networks by bringing genetic elements into spatial proximity with a multitude of Cas protein staples.

Figure 21: Increasing the distance between Cas staple targets to 980 nucleotides stabilizes multiplexing.

6. References

Wu, W., Zhang, L., Yao, L., Tan, X., Liu, X., & Lu, X. (2015). Genetically assembled fluorescent biosensor for in situ detection of bio-synthesized alkanes. Scientific reports, 5, 10907. https://doi.org/10.1038/srep10907